Bottom line
How much do GDOC and VGHCX overlap?
50% of their top holdings overlap by weight. 11 securities appear in both funds' top 25, making up 52.2% of GDOC's assets and 37.6% of VGHCX's. They share a meaningful core but differ in the rest of the portfolio.
VGHCX holds far more positions (97 vs 42), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings GDOC and VGHCX have in common
| Holding | % of GDOC | % of VGHCX | Overlap |
|---|---|---|---|
| Eli Lilly & Company LLY | 13.28% | 8.61% | 8.61% |
| Johnson & Johnson JNJ | 8.07% | 4.83% | 4.83% |
| Merck & Company Inc MRK | 5.94% | 5.44% | 5.44% |
| Astrazeneca Plc AZN | 4.84% | 4.59% | 4.59% |
| Intuitive Surgical Inc ISRG | 3.90% | 2.52% | 2.52% |
| Boston Scientific Corp BSX | 3.78% | 1.53% | 1.53% |
| Edwards Lifesciences Corp EW | 2.98% | 2.56% | 2.56% |
| Dexcom Inc DXCM | 2.79% | 1.18% | 1.18% |
| Agilent Technologies Inc A | 2.77% | 1.49% | 1.49% |
| Cencora Inc COR | 2.34% | 2.47% | 2.34% |
| Vertex Pharmaceuticals Inc VRTX | 1.48% | 2.36% | 1.48% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in GDOC
- Guardant Health Inc — 5.34%
- Thermo Fisher Scientific Inc — 4.52%
- Argenx Se — 4.07%
- Hoya Corp — 3.53%
- Lonza Group Ag — 2.80%
- Roivant Sciences Ltd — 2.39%
- Apogee Therapeutics Inc — 1.97%
- Royalty Pharma Plc — 1.77%
- Penumbra Inc — 1.61%
- Mettler-toledo International Inc — 1.59%
- Goldman Sachs Trust — 1.43%
- Cytokinetics Inc — 1.40%
- Ionis Pharmaceuticals Inc — 1.37%
- Xenon Pharmaceuticals Inc — 1.35%
Only in VGHCX
- UnitedHealth Group Inc — 4.05%
- Gsk Plc — 3.00%
- CVS Health Corp — 2.52%
- AbbVie Inc — 2.30%
- Danaher Corp — 2.18%
- Regeneron Pharmaceuticals Inc — 2.14%
- Novartis AG — 1.91%
- Elevance Health Inc — 1.83%
- Argenx SE — 1.68%
- HCA Healthcare Inc — 1.68%
- Ucb Sa — 1.67%
- Biogen Inc — 1.46%
- Galderma Group AG — 1.37%
- Roche Holding AG — 1.18%
Asset mix
| Asset type | GDOC | VGHCX |
|---|---|---|
| Stocks | 98.5% | 97.6% |
| Repurchase agreements | — | 2.2% |
| Cash & short-term funds | 1.4% | 0.1% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)
Country mix
| Country | GDOC | VGHCX |
|---|---|---|
| US | 76.3% | 77.6% |
| GB | 6.6% | 7.6% |
| JP | 3.5% | 4.8% |
| CH | 3.9% | 4.5% |
| NL | 4.1% | — |
| BE | — | 3.4% |
| BM | 2.4% | — |
| CA | 1.9% | — |
Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do GDOC and VGHCX overlap?
What stocks do GDOC and VGHCX have in common?
Should I own both GDOC and VGHCX?
Which holds more stocks, GDOC or VGHCX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.